Comment on the comment of Dr. Daniel Present

Am J Gastroenterol. 2002 Apr;97(4):1066. doi: 10.1111/j.1572-0241.2002.05635.x.
No abstract available

Publication types

  • Comment
  • Letter

MeSH terms

  • Antibodies, Monoclonal / adverse effects*
  • Antibodies, Monoclonal / therapeutic use*
  • Colitis, Ulcerative / drug therapy*
  • Controlled Clinical Trials as Topic*
  • Gastrointestinal Agents / adverse effects*
  • Gastrointestinal Agents / therapeutic use*
  • Humans
  • Infliximab

Substances

  • Antibodies, Monoclonal
  • Gastrointestinal Agents
  • Infliximab